Based on 9 analysts giving stock ratings to BIOAGE Labs Inc in the past month.
In the current month, BIOA has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BIOA average Analyst price target in the last month is 32.556.
Based on analysts' estimates, BIOA EPS is projected to reach -0.684 in FY2026Q4, following reported EPS of -0.730 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.73, while BIOAGE Labs IncBIOA's earnings per share (EPS) for the previous quarter was USD -0.58. EPS for the next quarter is expected at USD -0.68.